Human EEF2K activation kit by CRISPRa

CAT#: GA109302

EEF2K CRISPRa kit - CRISPR gene activation of human eukaryotic elongation factor 2 kinase



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Rabbit Polyclonal Anti-EEF2K Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


EEF2K (Myc-DDK-tagged)-Human eukaryotic elongation factor-2 kinase (EEF2K)
    • 10 ug

CNY 5,312.00
CNY 5,800.00


Phospho-EEF2K-S366 Rabbit polyclonal Antibody
    • 100 ul

CNY 2,900.00

热销推荐

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol EEF2K
Locus ID 29904
Kit Components

GA109302G1, EEF2K gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA109302G2, EEF2K gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA109302G3, EEF2K gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_013302
Synonyms eEF-2K; HSU93850
Summary This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...